These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Differential expression of major histocompatibility complex class Ia, Ib, and II molecules on monocytes-derived dendritic and macrophagic cells. Laupéze B; Fardel O; Onno M; Bertho N; Drénou B; Fauchet R; Amiot L Hum Immunol; 1999 Jul; 60(7):591-7. PubMed ID: 10426276 [TBL] [Abstract][Full Text] [Related]
4. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide. Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399 [TBL] [Abstract][Full Text] [Related]
5. Biogenesis of HLA Ligand Presentation in Immune Cells Upon Activation Reveals Changes in Peptide Length Preference. Marino F; Semilietof A; Michaux J; Pak HS; Coukos G; Müller M; Bassani-Sternberg M Front Immunol; 2020; 11():1981. PubMed ID: 32983136 [TBL] [Abstract][Full Text] [Related]
6. Composition of MHC class II-enriched lipid microdomains is modified during maturation of primary dendritic cells. Setterblad N; Roucard C; Bocaccio C; Abastado JP; Charron D; Mooney N J Leukoc Biol; 2003 Jul; 74(1):40-8. PubMed ID: 12832441 [TBL] [Abstract][Full Text] [Related]
7. HLA class II-restricted antigen presentation of endogenous bcr-abl fusion protein by chronic myelogenous leukemia-derived dendritic cells to CD4(+) T lymphocytes. Yasukawa M; Ohminami H; Kojima K; Hato T; Hasegawa A; Takahashi T; Hirai H; Fujita S Blood; 2001 Sep; 98(5):1498-505. PubMed ID: 11520800 [TBL] [Abstract][Full Text] [Related]
8. Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells. Nijman HW; Kleijmeer MJ; Ossevoort MA; Oorschot VM; Vierboom MP; van de Keur M; Kenemans P; Kast WM; Geuze HJ; Melief CJ J Exp Med; 1995 Jul; 182(1):163-74. PubMed ID: 7790816 [TBL] [Abstract][Full Text] [Related]
9. Optimizing the exogenous antigen loading of monocyte-derived dendritic cells. Dieckmann D; Schultz ES; Ring B; Chames P; Held G; Hoogenboom HR; Schuler G Int Immunol; 2005 May; 17(5):621-35. PubMed ID: 15824067 [TBL] [Abstract][Full Text] [Related]
10. A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells. Sioud M; Skorstad G; Mobergslien A; Sæbøe-Larssen S FASEB J; 2013 Aug; 27(8):3272-83. PubMed ID: 23671272 [TBL] [Abstract][Full Text] [Related]
12. Differential up-regulation of HLA-DM, invariant chain, and CD83 on myeloid and plasmacytoid dendritic cells from peripheral blood. Gómez J; Borràs FE; Singh R; Rajananthanan P; English N; Knight SC; Navarrete CV Tissue Antigens; 2004 Feb; 63(2):149-57. PubMed ID: 14705986 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells generated from CD34+ progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen-presenting cells resembling mature monocyte-derived dendritic cells. Ferlazzo G; Klein J; Paliard X; Wei WZ; Galy A J Immunother; 2000 Jan; 23(1):48-58. PubMed ID: 10687137 [TBL] [Abstract][Full Text] [Related]
14. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation. Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186 [TBL] [Abstract][Full Text] [Related]
15. Targeting of DEC-205 on human dendritic cells results in efficient MHC class II-restricted antigen presentation. Birkholz K; Schwenkert M; Kellner C; Gross S; Fey G; Schuler-Thurner B; Schuler G; Schaft N; Dörrie J Blood; 2010 Sep; 116(13):2277-85. PubMed ID: 20566893 [TBL] [Abstract][Full Text] [Related]
16. Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. Fallas JL; Tobin HM; Lou O; Guo D; Sant'Angelo DB; Denzin LK J Immunol; 2004 Aug; 173(3):1549-60. PubMed ID: 15265882 [TBL] [Abstract][Full Text] [Related]
17. Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy. Ikuta Y; Katayama N; Wang L; Okugawa T; Takahashi Y; Schmitt M; Gu X; Watanabe M; Akiyoshi K; Nakamura H; Kuribayashi K; Sunamoto J; Shiku H Blood; 2002 May; 99(10):3717-24. PubMed ID: 11986228 [TBL] [Abstract][Full Text] [Related]
18. Areca nut extracts suppress the differentiation and functionality of human monocyte-derived dendritic cells. Wang CC; Chen TY; Wu HY; Liu TY; Jan TR J Periodontal Res; 2012 Apr; 47(2):198-203. PubMed ID: 21958362 [TBL] [Abstract][Full Text] [Related]
19. Retrovirally transduced human dendritic cells can generate T cells recognizing multiple MHC class I and class II epitopes from the melanoma antigen glycoprotein 100. Lapointe R; Royal RE; Reeves ME; Altomare I; Robbins PF; Hwu P J Immunol; 2001 Oct; 167(8):4758-64. PubMed ID: 11591807 [TBL] [Abstract][Full Text] [Related]
20. Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors. Lotem M; Zhao Y; Riley J; Hwu P; Morgan RA; Rosenberg SA; Parkhurst MR J Immunother; 2006; 29(6):616-27. PubMed ID: 17063124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]